Results: nejm.org/doi/full/10.10 #ADA2023 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial results demonstrating 25% weight loss in half of people with #obesity
Isso significa que, sem uma dieta apropriada que restrinja o consumo de alimentos gordurosos, o orlistat acaba no tendo um efeito relevante, pois, se o paciente consome muito mais gorduras do que precisa, mesmo com a reduo de 30% na sua absoro, uma quantidade grande ainda ser assimilada
Valid sequences were obtained by differentiating the samples based on the barcodes and primer sequences at the beginning and end of the sequences, followed by correcting the sequence orientation
Some people prefer to use a powdered version, while others like the convenience and ease of pills
The medicine encourages the special area of the brain to make more growth hormone